Van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM; Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine, 2003 Sep 1, 28(17): 1978-92.

Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract, 2004, 17: S23-31.

Morikawa K, Oshita M, Yamazaki M, Ohara N, Mizutani F, Kato H, Ito Y, Kontani H, Koshiura R. Pharmacological studies of the new centrally acting muscle relaxant 4’-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride. Arzneimittelforschung, 1987 Mar, 37(3): 331-6.

Tekes K. Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant. Open Med Chem J, 2014, 8: 17–22.

Ono H, Fukuda H, Kudo Y. Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. J Pharmacobiodyn, 1984 Mar, 7(3): 171-6.

Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled doubleblind trial. Pain, 1996, 67(2-3): 417-425.

Kohne-Volland R. RGD: 53669/G. The study performed in Germany investigating the efficacy and tolerability of tolperisone on 5130 patients suffering in painful muscle spasm, 1999.